There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AdaptHealth (AHCO – Research Report), Allogene Therapeutics (ALLO – Research Report) and Privia Health Group (PRVA – Research Report) with bullish sentiments.
AdaptHealth (AHCO)
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on AdaptHealth, with a price target of $13.00. The company’s shares closed last Tuesday at $9.83.
According to TipRanks.com, Macdonald is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for AdaptHealth with a $11.85 average price target, implying a 21.4% upside from current levels. In a report issued on May 7, Canaccord Genuity also maintained a Buy rating on the stock with a $14.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Allogene Therapeutics (ALLO)
Truist Financial analyst Asthika Goonewardene maintained a Buy rating on Allogene Therapeutics today. The company’s shares closed last Tuesday at $2.96, close to its 52-week low of $2.23.
According to TipRanks.com, Goonewardene is a 1-star analyst with an average return of
Currently, the analyst consensus on Allogene Therapeutics is a Strong Buy with an average price target of $13.27, which is a 308.3% upside from current levels. In a report issued on May 13, RBC Capital also maintained a Buy rating on the stock with a $10.00 price target.
Privia Health Group (PRVA)
Truist Financial analyst Jailendra Singh maintained a Buy rating on Privia Health Group today and set a price target of $24.00. The company’s shares closed last Tuesday at $18.05, close to its 52-week low of $16.90.
According to TipRanks.com, Singh ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Privia Health Group with a $25.86 average price target, implying a 41.0% upside from current levels. In a report issued on May 2, Stifel Nicolaus also maintained a Buy rating on the stock with a $24.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AHCO:
